TYK2 drugs for Psoriatic Arthritis

4 tracked TYK2 drugs in the Psoriatic Arthritis race. The class explanation lives on the TYK2 page; the full indication pipeline across every mechanism is on the Psoriatic Arthritis page.

1 approved / phase 41 Phase 32 Phase 2

Head-to-head evidence: deucravacitinib vs HS-10374 · deucravacitinib vs TQH3906 · deucravacitinib vs zasocitinib

The roster

← all TYK2 drugs